1. Introduction
===============

Rheumatoid arthritis (RA) is an autoimmune disease that results in a chronic, systemic inflammatory disorder that may affect many tissues and organs, but principally attacks synovial joints. It can be a disabling and painful condition, which can lead to substantial loss of functioning and mobility if not treated.^\[[@R1]\]^ Severity of RA is assessed using the disease activity score in 28 joints (DAS28),^\[[@R2]\]^ which is a composite score comprising clinician report of signs, patient self-report, and biochemical measures. It was developed originally to enable the monitoring of RA activity and is the standard measure used to gauge response to therapy. Anxiety and depression are higher in patients with chronic medical diseases than general population (15%--23% vs 6.6%).^\[[@R3]\]^ Given that RA is a chronic disease, anxiety and depression are more common among patients with RA, compared with the general population (28%--44% vs 6.6%)^\[[@R3]--[@R5]\]^ and the condition has been associated with increased pain, fatigue, physical disability and healthcare costs, and overall reduced health-related quality of life. They have poorer long-term outcomes, including increased pain, comorbidities, and mortality levels.^\[[@R6]\]^ The literature is rich with studies concerning psychological affection in RA patients and correlating it to disease activity and severity parameters. However, these studies showed markedly variable results due to different study designs and different methods for assessment. This study aimed at assessing the prevalence of psychological affection in RA patients, using the International Classification of Mental and Behavioral Disorders tenth revision (ICD-10) criteria as standard method for assessment, in addition to its relationship to disease activity parameters.

2. Methods
==========

Twenty-five patients who fulfilled the 2010 RA classification criteria^\[[@R7]\]^ by the American College of Rheumatology (ACR)/European League Against Rheumatism were included in this national, cross-sectional, single-center study. These patients were recruited from rheumatology outpatient clinics consecutively over the 6-month study duration. Twenty-five healthy age and sex-matched individuals constituted the control group. Signed informed consent form was taken for every patient and control subject, and the study was approved by the Ethics Committee at Minya University. Were excluded from the study population, patients with depressive episode attributable to psychoactive substance use or to any organic mental disorder or with psychotic symptoms as hallucinations, delusions, or depressive stupor also anxiety sustained by a physical disorder, such as hyperthyroidism, an organic mental disorder or psychoactive substance-related disorder.

All patients were subjected to clinical evaluation (full history and examination including Ritchie articular index 28 tender and swollen joint count), laboratory evaluation (erythrocyte sedimentation rate \[ESR\], C reactive protein \[CRP\] and rheumatoid factor \[RF\]), in addition to assessment of disease activity and outcome measures (disease activity score in 28 joints \[DAS28\]-ESR,^\[[@R2]\]^ health assessment questionnaire disability index \[HAQ-DI\]^\[[@R8]\]^ and the 10-Likert visual analog scale \[VAS\]^\[[@R9]\]^). Psychological assessment was performed according to the ICD-10.^\[[@R10]\]^

2.1. Statistical analysis
-------------------------

Quantitative variables were summarized by number of observed values, mean, standard deviation, range, and median. Chi-square and 2-tailed tests were used throughout to analyze correlation between disease activity scores and psychological signs, as well as significance of differences between RA patient group and their healthy counterparts; statistical significance was set at the conventional level of *P* value \< .05. Regression analysis was used to determine activity and severity predictors. The SPSS software version 16.0 was used for statistical analyses.

3. Results
==========

3.1. Demographic characteristics of patients
--------------------------------------------

The group of RA patients included 23 female (92%) and 2 male (8%) patients, with a mean age of 41.32 ± 10.74 years. Control group included 22 female (88%) and 3 male (12%) patients, with a mean age of 36.92 ± 10.65 years.

3.2. Disease characteristics
----------------------------

Regarding clinical and laboratory disease activity measurements in the RA patients, 24 (96%) patients had arthritis, while 14 (56%) patients had arthralgia, 19 (76%) patients had morning stiffness more than 1 hour, 6 (24%) patients had fever, 21 (84%) patients had myalgia, 24 (96%) of patients were receiving drugs, 16 (64%) were on nonsteroidal anti-inflammatory drugs, while 19 (76%) were on methotrexate, 23 (92%) on antimalarial medication, 7 (28%) on leflunomide, and 11 (44%) patients on steroids. ESR levels were at 45.24 ± 21.55 with a median of 40 (range 11--100) and 80% of RA patients were positive for CRP and 84% for RF.

3.3. Disease activity and disability indices in RA group
--------------------------------------------------------

Table [1](#T1){ref-type="table"} shows that only 1 patient (4%) had mild DAS28 score (\>2.6--≤3.2), 7 patients (28%) had moderate disease activity with a DAS28 score (\>3.2--≤5.1), and 13 (52%) patients had high disease activity according to a DAS28 score \>5.1. Four patients (16%) were in remission (DAS28 ≤2.6). The HAQ-DI score ranged from 0 to 3 with median of 3 and mean of 20.96 ± 0.84; 14 (56%) patients had mild impairment according to their HAQ-DI score, 2 (8%) patients had moderate impairment, 2 (8%) patients had complete impairment, and 7 (28%) patients presented no impairment. The VAS score ranged from 0 to 3 with median of 2 and mean of 1.72 ± 0.84; 7 (28%) patients had mild pain, 12 (48%) had moderate pain, 4 (16%) had severe pain, and only 2 (8%) patients had no pain. The articular index of RA group ranged from 0 to 46 with median of 11 and mean of 12.36 ± 9.46.
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Disease activity and disability indices.
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3.4. Psychological status of RA patients
----------------------------------------

Psychological evaluation of RA patients found that over 50% of patients had severe depressive symptoms (14 \[56%\] patients), while only 2 (8%) patients displayed mild symptoms and 4 (16%) patients had moderate symptoms. Table [2](#T2){ref-type="table"} also shows that 16 (64%) patients had recurrent depression, another 16 had somatic symptoms, and 13 (52%) patients had anxiety. In the control group, on the other hand, only 2 (8%) subjects reported mild depressive symptoms, 1 (4%) had somatic symptoms, and 2 (8%) had anxiety symptoms. Psychological disorders were, therefore, more frequent among RA patients, compared to control subjects (Table [2](#T2){ref-type="table"}, *P* \< .001). Figure [1](#F1){ref-type="fig"} displays the correlation of disease activity with depression and anxiety.
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Comparison of psychological data in RA and control groups.
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![Correlation between disease activity score and (A) depression and (B) anxiety. DAS28 = disease activity score-28 items.](medi-98-e15373-g003){#F1}

3.5. Correlation between RA disease parameters and psychological manifestations
-------------------------------------------------------------------------------

Table [3](#T3){ref-type="table"} shows that depressive symptoms (*P* = .002), recurrent depression (*P* = .02), and somatic manifestation (*P* = .002) were mostly associated with moderate to severe disease activity; anxiety was also only reported among RA patients with elevated DAS28 scores, but correlation did not reach statistical significance (*P* = .09). Patients who were in remission reported no psychological manifestations. CRP levels did not correlate with any of the psychological factors; ESR was used to calculate DAS28, and was not correlated with any psychological factor neither.
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Correlation between RA disease parameters and psychological data.
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This table also shows that all patients with complete impairment had severe depression (*P* = .08), recurrent depression (*P* = .37), and somatic symptoms (*P* = .01).

All patients with severe pain, as evaluated by the VAS, had severe depression (*P* = .01), recurrent depressive episodes (*P* = .02), and most of them had anxiety (3 out of 4 patients \[75%\]) though not to a significant extent.

4. Discussion
=============

The present study aimed primarily at evaluating prevalence of psychological affection in RA patients, in a specialized center in Upper Egypt.

It included 23 female (92%) and 2 male (8%) patients who had had RA for 3.68 ± 2.32 years and 25 healthy subjects. Though the sample size was quite limited with a total of 50 participants, it compares to a recent study performed on RA patients in the same Egyptian region of Minya.^\[[@R11]\]^ The large prevalence of RA among women in our study also matched the gender imbalance reported by the same study on RA patients in Minya.^\[[@R11]\]^ This overrepresentation of women was also underlined in a 2009 review, which discussed the potential involvement of sex hormones in RA onset and evolution.^\[[@R12]\]^ In this study, patients were relatively young, with an average age of 41 years; which also could explain female gender prevalence, in accordance with a 2006 study which reported than below the age of 50, females have a 4 to 5 times higher incidence rate of RA than their male counterparts, while the female/male ratio above the age of 60 to 70 years goes to only about 2.^\[[@R13]\]^

The vast majority of patients (80%) had depression, whether mild (2 patients), moderate (4 patients), or severe (16 patients), classified according to ICD-10 classification of Mental and Behavioral Disorders.

Findings demonstrated a highly significant correlation between occurrence of depressive symptoms, recurrent depressive episodes, and somatic manifestation (marked loss of interest in regular activities, appetite, libido, and lack of emotional reaction) with severity of disease activity in RA patients as assessed by the DAS28 tool.

The results of the present study were in agreement with Muhammad et al who studied 102 RA patients diagnosed according to the 1987 ACR criteria.^\[[@R14]\]^ Though disease duration reported in that study was longer than reports of the present study, gender distribution, and average age of patients were closely comparable. Importantly, over 70% of RA patients were found to have depression (over 40% reported moderate-to-severe cases), significantly correlated with the severity of disease.

In addition, the study by Mostafa et al on 170 RA patients found a positive significant correlation between depressive symptoms and disease activity of patients.^\[[@R15]\]^

There is in disagreement with Cordingley et al who studied 322 RA patients with active disease (mean DAS28 = 6.0) and found that there was no significant correlation between depression and disease activity^\[[@R16]\]^; this discrepancy may be due to the use of hospital anxiety and depression scale in assessing depression instead of the ICD-10international classification of Mental and Behavioral Disorders.

On the other hand and comparing with the same study,^\[[@R16]\]^ our data also showed no significant correlation between anxiety symptoms and disease activity of RA patients assessed by DAS28, also matching findings by Khedr et al.^\[[@R17]\]^

In our study, we found that the frequency of psychological disorders in RA patients was 80%, compared with 20% in controls. Specifically, RA patients displayed a significantly higher frequency of psychological disorders (depression: *P* = .0001 and somatic manifestations: *P* = .0006), when compared to their RA-free counterparts. These results were in agreement with Khedr et al where frequency of psychological disorders in RA patients was 60.8%, compared with 12% in controls (anxiety, somatoform disorder, and depression).^\[[@R17]\]^ The present study found a significant correlation between somatic manifestations and HAQ-DI score of RA patients (*P* = .01), in accordance with Muhammad et al,^\[[@R14]\]^ but no significant correlation existed between depressive symptoms, recurrent depressive episodes and anxiety symptoms, and extent of impairment among RA patients.

In our study, depression correlated significantly with VAS pain score (*P* = .01), matching results by 2 studies.^\[[@R17],[@R18]\]^

5. Limitations
==============

This work explores a small sample of patients and control subjects; in fact, no sample size calculation was performed, and this study serves as an exploratory investigation of the problem, which warrants a larger study and follow-up over time.

6. Conclusion
=============

Psychological manifestations are common in RA and they positively correlate with severity of disease activity.

7. Recommendations
==================

Psychological examination should be routinely undertaken in patients with rheumatic diseases, and special attention should be given to depression and anxiety, given their strong relationship to severity of the disease.

As psychological affectation in RA patients affects disease outcome and increases morbidity psychological evaluation would provide a more accurate and earlier diagnosis, which would lead to better clinical care and preventing debilitating changes and subsequent physical dysfunctions and impairment of the quality of life of RA patients.
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